COMMUNIQUÉS West-GlobeNewswire

HealthEx Empowers Consumers to Bring Their Personal Health History to Muse, Meta’s New Personal AI Agent
08/09/2026
Americans can connect their health history to Muse using HealthEx and make progress on their health goals with a plan that adapts to their life as their clinical context changes SAN FRANCISCO, Sept. 08, 2026 (GLOBE [...]
Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program
08/09/2026
– Assembly Bio to share 40% of U.S. development costs and profits for helicase-primase inhibitor program for recurrent genital herpes – – Cash runway remains projected into 2029, including the first $75 million [...]
Starton Therapeutics Appoints Experienced Finance Executive Saleem Elmasri, CPA, as Chief Financial Officer
08/09/2026
Experienced finance executive and former Big Four auditor to lead corporate finance strategy, and capital markets initiatives PARAMUS, N.J., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc . (“Starton”), a [...]
Inventiva présentera plusieurs abstracts lors du Congrès Paris MASH 2026
08/09/2026
Des données d’études cliniques de Phase 1 et Phase 2 montrent que le lanifibranor améliore le profil métabolique et certains facteurs de risque cardiovasculaire chez les patients atteints de MASH, avec ou sans diabète [...]
Inventiva to Present Multiple Abstracts at Paris MASH 2026
08/09/2026
Phase 1 and Phase 2 clinical data showed lanifibranor improves metabolic profile and cardiovascular risk factors in patients with MASH with or without type 2 diabetes Preclinical data further characterize lanifibranor’s [...]
Ascendis Pharma to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
08/09/2026
COPENHAGEN, Denmark, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare [...]
Pyxis Oncology to Host Webcast to Present Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+ R/M HNSCC)
08/09/2026
Event to be webcast live on September 9, 2026 at 7:30 a.m. ET BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for [...]
Keros Therapeutics Announces $5 Million Share Repurchase Authorization
08/09/2026
LEXINGTON, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel [...]
Celldex to Present at Upcoming Investor Conference
08/09/2026
HAMPTON, N.J., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that management will participate in a fireside chat at the upcoming Cantor Global Healthcare Conference on September 10, 2026 at 8: [...]
Lakefront to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
08/09/2026
Mechelen, Belgium; 8 September 2026, 22.01 CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that the Company will host a fireside chat at the Morgan Stanley 24th Annual Global Healthcare [...]
Acquisition of Own Shares
08/09/2026
Mechelen, Belgium; 08 September 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") [...]
Braveheart Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
08/09/2026
Phase 3 LIONHEART-HCM Trial of BHB-1893 in Obstructive Hypertrophic Cardiomyopathy (oHCM) Initiated Cash and Cash Equivalents of $122.8 Million as of June 30, 2026, or $527.3 Million After Giving Effect to Braveheart [...]
BBOT Announces New BBO-8520 Data; Highlights Strategic Focus on 2L+ NSCLC BBO-8520 Combination as Well as BBO-11818 and BBO-10203 Combinations in KRAS-Mutant Cancers
08/09/2026
BBO-8520 plus pembrolizumab demonstrated a 75% ORR at 500 mg QD and 53% ORR across dose levels in 2L+ KRAS G12C inhibitor-experienced NSCLC patients BBO-8520 monotherapy continues to show highly competitive ORR in the [...]
Carlsmed, Inc. Announces Chief Operating Officer Appointment
08/09/2026
CARLSBAD, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced [...]
Journey Medical Corporation to Participate in September 2026 Investor Conferences
08/09/2026
SCOTTSDALE, Ariz., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”) (Nasdaq: DERM), a commercial-stage pharmaceutical company focused on developing, selling and marketing U.S. Food and [...]
InnovAge Announces Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2026
08/09/2026
DENVER, Sept. 08, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible [...]
Protara Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
08/09/2026
NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that [...]
CAMP4 Therapeutics to Host Virtual Analyst Day to Discuss CMP-002 for the Treatment of SYNGAP1-Related Disorder on September 28, 2026
08/09/2026
WATERTOWN, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics [...]
New meta-analysis shows statistically significant improvements in patient outcomes associated with da Vinci surgery versus laparoscopic and open surgery across 13 common benign conditions
08/09/2026
Largest comparative meta-analysis of its kind found da Vinci robotic-assisted surgery was associated with shorter hospital stays and a faster return to work compared with laparoscopic and open surgery SUNNYVALE, Calif [...]

Pages